SEPTInvestingStart Free

GRCE SCHEDULE 13G/A: SEC filing

Nantahala Capital Management

Filed with the SEC on · accession 0001104659-26-127216

GRCE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. Nantahala Capital Management filed an amended Schedule 13G reporting beneficial ownership of 1,654,393 shares (7.45%) of Grace Therapeutics, including 1,178,203 shares acquirable within 60 days via convertible securities. The stock moved +0.0% by the first close after the filing.

Summary of the filing

Nantahala Capital Management filed an amended Schedule 13G reporting beneficial ownership of 1,654,393 shares (7.45%) of Grace Therapeutics, including 1,178,203 shares acquirable within 60 days via convertible securities. The filing is a passive investment disclosure with no stated intent to influence control.

For details, click here →

Key details

Shares beneficially owned$1.7M
Shares acquirable within 60 days via convertible securities$1.2M
Reporting person / beneficial ownerNantahala Capital Management, LLC
IssuerGrace Therapeutics, Inc.
Managing member, nantahala capital managementWilmot B. Harkey
Managing member, nantahala capital managementDaniel Mack
Chief compliance officer, nantahala capital managementTaki Vasilakis

How GRCE stock reacted

Close before

$1.81

Nov 12, 2026

First close after

+0.00%

$1.81

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for GRCE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for GRCE?

Click here

Frequently asked questions

What did GRCE file with the SEC on Nov 13, 2026?

GRCE filed a SCHEDULE 13G/A (SEC filing). Nantahala Capital Management filed an amended Schedule 13G reporting beneficial ownership of 1,654,393 shares (7.45%) of Grace Therapeutics, including 1,178,203 shares acquirable within 60 days via convertible securities. The filing is a passive investment disclosure with no stated intent to influence control.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did GRCE stock react to this filing?

GRCE closed at $1.81 before the filing and $1.81 on Nov 13, 2026 (+0.00%).

Other GRCE SEC filings

Get alerts when GRCE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
GRCE overviewGRCE analysisGRCE newsLatest SEC filings